CASE REPORT A 74-year-old male with peripheral T-cell non-Hodgkin’s Lymphoma (NHL) s/p stem cell transplant in November 2010 and recurrent CD30+ T-cell lymphoproliferative disorder/anaplastic large cell lymphoma (ALCL) treated with…
Read More
INTRODUCTION Epithelioid angiosarcoma (EA) is a rare, more aggressive form of angiosarcoma characterized by anaplastic cells originating from the vessel lining of irregularly blood-filled spaces. EA can resemble a bruise…
Read More
ROSACEAGenetic Basis of Rosacea Study Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome…
Read More
BACKGROUND Psoriasis is a chronic, immune-mediated disorder affecting 2-3% of the global population and is most often characterized by erythematous, indurated, and scaly plaques. In addition to its cutaneous manifestations,…
Read More
INTRODUCTION Atopic dermatitis (AD) is a common, chronic, relapsing inflammatory skin disease characterized by erythema, pruritis, xerosis, excoriations, seepage, crusting, and lichenification. Its prevalence in the United States is 10.7%1…
Read More
INTRODUCTION Psoriasis is a chronic inflammatory, systemic immune-mediated disease of that affects the skin and joints and is associated with multiple comorbidities1. The effect on quality of life is severe…
Read More
INTRODUCTION Unfortunately, clinical trials all must end and in doing so, any benefits that may have been achieved by the study subject volunteering for the clinical trial may be lost,…
Read More
BACKGROUND Cortisol is an endogenous glucocorticoid produced in the adrenal gland under physiological stress conditions (eg infection, tissue injury, trauma) and is required for normal cellular function, including immune function,…
Read More
INTRODUCTION Psoriasis vulgaris is a chronic inflammatory disease1,2 with an impact on patient quality of life (QoL) comparable to other chronic diseases, such as cardiovascular disease and type 2 diabetes.3…
Read More
INTRODUCTION The safety and efficacy of ixekizumab, a monoclonal antibody that selectively targets interleukin-17A, have been established in 3 Phase 3 trials for the treatment of moderate to severe plaque…
Read More
INTRODUCTION Acne vulgaris (acne), a common dermatologic disorder in adolescents and adults,1 can negatively impact an individual’s quality of life and psychological well-being.2-4 Effective treatment of acne symptoms may improve…
Read More
INTRODUCTION Onychomycosis continues to be a common and intractable problem in adults, often responding poorly to drug treatment. Toenails are most frequently affected by the infection, particularly the hallux.1 Studies…
Read More





